This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Hai Kang Life Corporation Limited. Active years: 2019-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2022
Title: Innovations by Bo Liang Jia in Biochip Technology
Introduction
Bo Liang Jia is a notable inventor based in Hong Kong, CN. He has made significant contributions to the field of biochip technology, holding 2 patents that focus on methods for detecting and sequencing biomolecules. His work is pivotal in advancing the capabilities of biochips, which are essential tools in biotechnology and medical diagnostics.
Latest Patents
Bo Liang Jia's latest patents include innovative methods for fabricating biochips designed for biomolecule detection and sequencing. One of his patents describes a biochip that consists of a base member and a dielectric layer with discrete recesses. This design allows for the application of an electric field through electrodes, creating a field gradient that draws biomolecules to specific areas of the operation surface. Another patent outlines a similar biochip structure, emphasizing the importance of the dielectric layer and electrodes in facilitating biomolecule detection.
Career Highlights
Bo Liang Jia is currently associated with Hai Kang Life Corporation Limited, where he continues to develop cutting-edge technologies in the field of biochips. His work has garnered attention for its potential applications in various scientific and medical fields.
Collaborations
He collaborates with talented coworkers such as Cheung Hoi Yu and Cheng Chang Lai, contributing to a dynamic research environment that fosters innovation and development in biochip technology.
Conclusion
Bo Liang Jia's contributions to biochip technology through his patents and collaborations highlight his role as a key innovator in the field. His work not only advances scientific understanding but also paves the way for future developments in biomolecular detection and sequencing.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile